A COMPARATIVE STUDY – CLINICORADIOGRAPHICAL PROFILE OF PULMONARY TUBERCULOSIS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS & NON DIABETIC PATIENTS

Dr. Sonika Chaudhary, Dr. Y. N Verma

Abstract


Tuberculosis is a communicable disease that is a major cause of ill health, and one of the top 10 causes of death worldwide and the leading cause of death from a single infectious agent (ranking above HIV/AIDS). CBNAAT marks an important development in the field of rapid molecular tuberculosis diagnosis. Diabetes triples the risk of developing tuberculosis, and poor glycemic control adversely affects tuberculosis treatment outcomes with effects such as prolongation of culture conversion, treatment failure, relapse, and death.


Keywords


Clinicoradiographical, Pulmonary, Tuberculosis

Full Text:

PDF

References


RNTCP; National strategic plan for Tuberculosis elimination 2017-2025;chap. 4- lab systems and diagnosis, pg 18

WHO, chest radiography in tuberculosis detection, The End TB strategy, pg 2

Stephen D Lawn and Alimuddin I Zumla; Diagnosis of extrapulmonary tuberculosis using the Xpert MTB/RIF assay; Expert Rev Anti Infect Ther. 2012: 10(6): 631–635

Jean jacques et al.; Global prevalence of diabetes in active tuberculosis: a systematic review and meta- analysis of data from 2-3 million patients with tuberculosis; 2019: 7(4) : 448-460

Rami H. Al-Rifai ,Fiona Pearson,Julia A. Critchley,Laith J. Abu-Raddad

Association between diabetes mellitus and active tuberculosis: systematic review and meta-analysis; 2017.

Harries AD, Lin Y, Satyanarayana S, Lönnroth K, Li L, Wilson N, et al. The looming epidemic of diabetes associated tuberculosis: learning lessons from HIV-associated tuberculosis. Int J Tuberc Lung Dis 2011;15:1436-44.

Harries AD, Satyanarayana S, Kumar AM, Nagaraja SB, Isaakidis P, Malhotra S, et al. Epidemiology and interaction of diabetes mellitus and tuberculosis and challenges for care: Areview. Public Health Action 2013;3 Suppl 1:S3-9.

Guptan ASA: Tuberculosis and diabetes: an appraisal. Ind J Tub 2000, 47: 3–8.

Ruslami R, Aarnoutse RE, Alisjahbana B, van der Ven AJ, Van Crevel R: Implications of the global increase of diabetes for tuberculosis control and patient care. Trop Med Int Health 2010,15(11):1289–1299

Alisjahbana B, Sahiratmadja E, Nelwan EJ, Purwa AM, Ahmad Y, Ottenhoff TH, Nelwan RH, Parwati I, van der Meer JW, Van Crevel R: The effect of type 2 diabetes mellitus on the presentation and treatment response of pulmonary tuberculosis. Clin Infect Dis 2007,45(4):428–435.

Dooley KE, Chaisson RE: Tuberculosis and diabetes mellitus: convergence of two epidemics. Lancet Infect Dis2009,9(12):737–746.

Wang JY, Lee LN, Hsueh PR: Factors changing the manifestation of pulmonary tuberculosis. Int J Tuberc Lung Dis2005,9(7):777–783.

Bashar M, Alcabes P, Rom WN, Condos R: Increased incidence of multidrug-resistant tuberculosis in diabetic patients on the Bellevue chest service, 1987 to 1997. Chest 2001,120(5):1514–1519

Ocal S, Saka D, Ogretensoy M: Mild and severe forms of tuberculosis in diabetic and non-diabetic patients. J Diabetes2009,1(2):107–111.


Refbacks

  • There are currently no refbacks.